Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MS

You must log in or register to reply here.

Similar threads

H
Experimental malaria monoclonal antibody protective in Malian children
Replies
0
Views
3
Health - Medical Xpress - latest medical and
H
M
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic S
Replies
0
Views
3
Money - r/Investing
M
A
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial
Replies
0
Views
2
Adorable Antelope
A
M
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003
Replies
0
Views
2
Money - r/Investing
M
A
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients w
Replies
0
Views
3
Adorable Antelope
A

Members Online

No members online now.
Total: 231 (members: 0, guests: 231)

Trending Content

Latest Media

LASTHJ8.mp4
Battlefield 4 2021.01.07 - 12.00.46.03.DVR-1.mp4
PERKY.png
Image1.png
Image1.jpg
holy-necrobump-batman.jpg

Featured Content

Latest Forum Posts

Forum Statistics

Threads
161,149
Messages
162,230
Members
80
Latest member
Roger Ebert
Top